☆
4.5
Article
Melphalan 200 mg/m2 with blood stem cell support as first-line myeloma therapy:: impact of glomerular filtration rate on engraftment, transplantation-related toxicity and survival
BONE MARROW TRANSPLANTATION (2005)
Rate this paper
The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now